DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Iquix (Levofloxacin Ophthalmic) - Indications and Dosage

 
 



INDICATIONS AND USAGE

IQUIX® solution is indicated for the treatment of corneal ulcer caused by susceptible strains of the following bacteria:

GRAM-POSITIVE BACTERIA: GRAM-NEGATIVE BACTERIA:
Corynebacterium species 1 Pseudomonas aeruginosa
Staphylococcus aureus Serratia marcescens
Staphylococcus epidermidis
Streptococcus pneumoniae
Viridans group streptococci

1 Efficacy for this organism was studied in fewer than 10 infections.

DOSAGE AND ADMINISTRATION

Days 1 through 3

Instill one to two drops in the affected eye(s) every 30 minutes to 2 hours while awake and approximately 4 and 6 hours after retiring.

Day 4 through treatment completion

Instill one to two drops in the affected eye(s) every 1 to 4 hours while awake.

HOW SUPPLIED

IQUIX® (levofloxacin ophthalmic solution) 1.5% is supplied in a white, low density polyethylene bottle with a controlled dropper tip and a tan, high density polyethylene cap in the following size:

5 mL fill in 5 cc container– NDC 68669-145-05

Storage

Store at 15° – 25°C (59°– 77°F).

Rx Only.

Manufactured by:
Santen Oy, P.O. Box 33, FIN-33721 Tampere, Finland

Marketed by:
VISTAKON® Pharmaceuticals, LLC
Jacksonville, FL 32256 USA

Licensed from:
Daiichi Sankyo Co., Ltd., Tokyo, Japan

U.S. PAT. NO 5,053,407

April 2007 Version

3221050/3

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017